# EDGAR Filing Document

**Accession Number:** 0001711786
**File Stem:** 0001213900-25-117325
**Filing Date:** 2025-12
**Character Count:** 2170
**Document Hash:** 751a7189129bf66d7cab0513c0a057e1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-117325.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001213900-25-117325

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hoth Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001711786
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 821553794
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1177 AVENUE OF THE AMERICAS
- **STREET 2:** 5TH FLOOR SUITE 5066
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** (646)756-2997

**MAIL ADDRESS:**
- **STREET 1:** 1177 AVENUE OF THE AMERICAS
- **STREET 2:** 5TH FLOOR SUITE 5066
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**Hoth Therapeutics, Inc.**

**1177 Avenue of the Americas, 5th Floor, Suite 5066**

**New York, New York 10036**

December 2, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Doris Gama

---

| | |
|:---|:---|
| **Re:** | **Hoth Therapeutics, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-291566** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, December 4, 2025, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

---

| | |
|:---|:---|
| HOTH THERAPEUTICS, INC. | HOTH THERAPEUTICS, INC. |
| By: | /s/ Robb Knie |
| Name: | Robb Knie |
| Title: | Chief Executive Officer |

---